EUROPEAN FINANCIAL SERVICES
European Financial Services
Horizon 2020 is the European Commission programme for financing European research and innovation projects. The goal is to ensure Europe continues to produce world-class science projects.
In 2014 Horizon 2020 started with a budget of €80 billion for the next seven years, to invest in innovative projects. The programme aims to invest in our future, in sustainable and inclusive growth, and jobs. To achieve this, Horizon 2020 couples research and innovation with its emphasis on industrial leadership, excellent science and tackling societal challenges. The goal is to ensure that Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation.
IMPORTANT UPDATE
The European Commission has an update to Horizon 2020 Calls. Due to the current situation with Covid-19, calls with deadlines between now and 15 April are extended. The exact dates and details will be published on each call and topic on their Funding and Tenders Portal. For now, the specific following calls are to be extended to 15 April:
– SC1-BHC-37-2020 Towards the new generation of clinical trials – trials methodology research
– SC1-BHC-06-2020 Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data
– SC1-BHC-11-2020 Advancing the safety assessment of chemicals without the use of animal testing
– SC1-BHC-17-2020 Global Alliance for Chronic Diseases (GACD) – Prevention and/or early diagnosis of cancer
– SC1-BHC-20A-2020 Pre-commercial procurement (PCP) for integrated care solutions
– SC1-BHC-20B-2020 Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases
– SC1-BHC-33-2020 Addressing low vaccine uptake
– SC1-BHC-34-2020 New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings
– SC1-BHC-35-2020 Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases
– SC1-BHC-36-2020 Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health
– SC1-DTH-12-2020 Use of Real-World Data to advance research on the management of complex chronic conditions
– SC1-HCC-10-2020 Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research
– SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine
– SC1-HCO-03-2020 Bridging the divide in health research and innovation – boosting return on investment
– SC1-HCO-07-2020 ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)
– SC1-HCO-14-2020 ERA-NET: Sustained collaboration of national and regional programmes in cancer research
– SC1-HCO-16-2020 ERA-NET: Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system
– SC1-HCO-17-2020 Coordinating and supporting research on the human microbiome in Europe and beyond
– SC1-HCO-18-2020 Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices
– SC1-HCO-19-2020 Reliable and accessible information on cell and gene-based therapies
– SC1-HCO-20-2020 Coordination of clinical research activities of the European Reference Networks
2nd stage deadline moved to 15 April 2020:
– SC1-BHC-08-2020 New interventions for Non-Communicable Diseases
– SC1-BHC-24-2020 Healthcare interventions for the management of the elderly multimorbid patient
– SC1-BHC-29-2020 Innovative actions for improving urban health and wellbeing addressing environment, climate and socioeconomic factors
– SC1-DTH-13-2020 Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care